Literature DB >> 21056970

Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen.

Uma K Misra1, Sturgis Payne, Salvatore V Pizzo.   

Abstract

GRP78, a well characterized chaperone in the endoplasmic reticulum, is critical to the unfolded protein response. More recently, it has been identified on the cell surface, where it has many roles. On cancer cells, it functions as a signaling receptor coupled to proproliferative/antiapoptotic and promigratory mechanisms. In the current study, we demonstrate that ligation of prostate cancer cell surface GRP78 by its natural ligand, activated α(2)-macroglobulin (α(2)M*), results in a 2-3-fold up-regulation in the synthesis of prostate-specific antigen (PSA). The PSA is secreted into the medium as an active proteinase, where it binds to native α(2)M. The resultant α(2)M·PSA complexes bind to GRP78, causing a 1.5-2-fold increase in the activation of MEK1/2, ERK1/2, S6K, and Akt, which is coupled with a 2-3-fold increase in DNA and protein synthesis. PSA is a marker for the progression of prostate cancer, but its mechanistic role in the disease is unclear. The present studies suggest that PSA may be involved in a signal transduction-dependent feedback loop, whereby it promotes a more aggressive behavior by human prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056970      PMCID: PMC3020732          DOI: 10.1074/jbc.M110.129767

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Selective upregulated expression of the alpha2-macroglobulin signaling receptor in highly metastatic 1-LN prostate carcinoma cells.

Authors:  I R Asplin; U K Misra; G Gawdi; M Gonzalez-Gronow; S V Pizzo
Journal:  Arch Biochem Biophys       Date:  2000-11-01       Impact factor: 4.013

2.  Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.

Authors:  Victor K Lin; Shih-Ya Wang; Nicholas C Boetticher; Dolores V Vazquez; Hossein Saboorian; John D McConnell; Claus G Roehrborn
Journal:  Prostate       Date:  2005-05-15       Impact factor: 4.104

3.  Biological determinants of cancer progression in men with prostate cancer.

Authors:  T A Stamey; J E McNeal; C M Yemoto; B M Sigal; I M Johnstone
Journal:  JAMA       Date:  1999-04-21       Impact factor: 56.272

4.  Progression of prostate cancer: diagnostic and prognostic utility of prostate-specific antigen, alpha2-macroglobulin, and their complexes.

Authors:  Y Kanoh; N Ohtani; T Ohara; T Mashiko; S Ohtani; S Egawa; S Baba; H Ohtani
Journal:  Oncol Rep       Date:  2001 May-Jun       Impact factor: 3.906

5.  Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK.

Authors:  Uma Kant Misra; Rohit Deedwania; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2005-05-20       Impact factor: 5.157

6.  The role of MTJ-1 in cell surface translocation of GRP78, a receptor for alpha 2-macroglobulin-dependent signaling.

Authors:  Uma Kant Misra; Mario Gonzalez-Gronow; Govind Gawdi; Salvatore Vincent Pizzo
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

7.  Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.

Authors:  Nagalakshmi Nadiminty; Wei Lou; Soo Ok Lee; Farideh Mehraein-Ghomi; Jason S Kirk; Jeffrey M Conroy; Haitao Zhang; Allen C Gao
Journal:  Clin Cancer Res       Date:  2006-03-01       Impact factor: 12.531

8.  Alpha-2-macroglobulin deficiency in patients with advanced prostate cancer.

Authors:  H Ohtani; M Saito; K Koshiba
Journal:  Oncology       Date:  1985       Impact factor: 2.935

9.  Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78.

Authors:  Uma Kant Misra; Rohit Deedwania; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2006-03-16       Impact factor: 5.157

10.  Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis.

Authors:  Uma Kant Misra; Yvonne Mowery; Steven Kaczowka; Salvatore Vincent Pizzo
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

View more
  30 in total

1.  Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses.

Authors:  Uma Kant Misra; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

2.  GRP78 and α2-macroglobulin are new promising targets for metastatic castrate-resistant prostate cancer treatment.

Authors:  P J Vlachostergios; R L Balmiki; R Daya
Journal:  Clin Transl Oncol       Date:  2015-07-02       Impact factor: 3.405

3.  Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.

Authors:  Fortunato Ferrara; Daniela I Staquicini; Wouter H P Driessen; Sara D'Angelo; Andrey S Dobroff; Marc Barry; Lesley C Lomo; Fernanda I Staquicini; Marina Cardó-Vila; Suren Soghomonyan; Mian M Alauddin; Leo G Flores; Marco A Arap; Richard C Lauer; Paul Mathew; Eleni Efstathiou; Ana M Aparicio; Patricia Troncoso; Nora M Navone; Christopher J Logothetis; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

4.  Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.

Authors:  Udhayakumar Gopal; Yvonne Mowery; Kenneth Young; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2019-07-29       Impact factor: 5.157

5.  Identification of potential tumor differentiation factor (TDF) receptor from steroid-responsive and steroid-resistant breast cancer cells.

Authors:  Izabela Sokolowska; Alisa G Woods; Mary Ann Gawinowicz; Urmi Roy; Costel C Darie
Journal:  J Biol Chem       Date:  2011-11-30       Impact factor: 5.157

Review 6.  The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies.

Authors:  B Luo; A S Lee
Journal:  Oncogene       Date:  2012-04-16       Impact factor: 9.867

Review 7.  Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.

Authors:  Daniel L J Thorek; Michael J Evans; Sigrid V Carlsson; David Ulmert; Hans Lilja
Journal:  Thromb Haemost       Date:  2013-08-01       Impact factor: 5.249

8.  Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.

Authors:  Ali A Al-Hashimi; Paul Lebeau; Fadwa Majeed; Enio Polena; Šárka Lhotak; Celeste A F Collins; Jehonathan H Pinthus; Mario Gonzalez-Gronow; Jen Hoogenes; Salvatore V Pizzo; Mark Crowther; Anil Kapoor; Janusz Rak; Gabriel Gyulay; Sara D'Angelo; Serena Marchiò; Renata Pasqualini; Wadih Arap; Bobby Shayegan; Richard C Austin
Journal:  J Biol Chem       Date:  2017-10-24       Impact factor: 5.157

9.  The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival.

Authors:  Koji Matsuo; Michael J Gray; Dong Yun Yang; Sucheta A Srivastava; Prem B Tripathi; Laura A Sonoda; Eun-Jeong Yoo; Louis Dubeau; Amy S Lee; Yvonne G Lin
Journal:  Gynecol Oncol       Date:  2012-11-28       Impact factor: 5.482

10.  AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers.

Authors:  Michael J Gray; Paulette Mhawech-Fauceglia; Eunjeong Yoo; Wangrong Yang; Eijean Wu; Amy S Lee; Yvonne G Lin
Journal:  Int J Cancer       Date:  2013-02-08       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.